DM Flashcards

(30 cards)

1
Q

High risk ethnic groups

A

African-American, Latino, Native American, Asian American, Pacific Islander.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Criteria for diabetes testing in asymptomatic adults

A

Patients that are overweight and have additional risk factors including:

Physical inactivity
first-degree relative with type two diabetes
members of High risk ethnic groups
history of gestational diabetes
hypertension
hyperlipidemia
polycystic ovarian syndrome
pre-diabetic lab results on previous testing
history of cardiovascular disease

Otherwise a screening for diabetes should begin at age 45 years. If results are normal, testing should repeat in at least three year intervals with consideration of more frequent testing depending on risk status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraindication for TZD

A

High risk for edema, avoid with congestive heart failure patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recommended for the use of cardiovascular disease in diabetics

A

GLP-1 agonist and SLGT2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indication for insulin

A

Type 1 diabetic

Type 2 diabetic when two or more drugs including insulin releasers no longer are adequate to maintain glycemic control, marker of beta cell failure

Highest risk of hypoglycemic affect but highest of efficiency on A-1 C reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindicator for GLP-1 agonists

A

FTA black box warning: risk of thyroid tumors. Avoid in patients with personal or family history of thyroid cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type 1 DM insulin plan

A

Basal or long acting = about 50% of total daily insulin

Bolus is rapid acting = about 50% of total daily insulin

Insulin pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indication for insulin and type 2 diabetes

A

At time of diagnoses A-1 C is greater than 9% with classic poly symptoms.

One more than two oral or injectable agents are in adequate to maintain glycemic control. This indicates beta cell dysfunction

Critically ill - tight control 140-180 important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

rapid acting insulin

A

Onset of action is 5 minutes
peak is 1 hour
duration is 4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Short acting insulin

A

Humulin R, Novolin R

Onset 30 min
Peak 2-3 hours
Duration 3-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Long-acting insulin

A

Perferred basal insulin

Insulin detemir (levemir) and insulin glargine (basaglar kwikpen, lantus, lantus pen, toujeo pen)

Onset 1-2 hours
NO PEAK
Duration 24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Intermediate acting NPH insulin

A

Used BID as alternative to basal insulin

Novolin N, Humulin N also known as 70/30 NPH/regular insulin

Inexpensive

Onset 1-2 hours
Peak 6-14 hours
Duration 16-24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Additional type two diabetes treatment considerations ABCDEFG

A

Aspirin
blood pressure control
cholesterol: Staten therapy usually indicated
creatinine or renal function
diet
dental care
exercise
Eye exams
annually foot examination with every visit
goals of therapy glycemic lipid physical activity and

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Microvascular damage

A

Retinopathy, nephropathy and neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Macrovascular damage

A

Atherosclerosis, heart disease (coronary artery disease, MI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Target organs of diabetes mellitus

A

Eyes, kidneys, heart or vascular system, peripheral nerves esp feet.

DM is the most common reason for chronic renal failure requiring dialysis and lower limb amputation in the United States

17
Q

Ketones

A

Abrupt cessation of insulin production causes body fat to be used as fuel which then breaks down into ketones. Ketones, the metabolic product of fat breakdown.

18
Q

Prediabetes

A

A1c between 5.7% and 6.4%

Fasting blood sugar of 100 to 125

19
Q

Diagnostic criteria for DM

A

A-1 C greater than 6.5%
fasting blood sugar greater than 126
symptoms of hyperglycemia plus random blood sugar 200 or two hour plasma glucose >200

20
Q

Goals of DM treatment: lab value normals

A

Fasting blood sugar of 70 to 100
post prandial plasma glucose less than 180
hemoglobin A1c <6

Less stringent alc (<8%) if elderly or frail patient. Increased risk of unawareness hypoglycemia

21
Q

Labs for management of diabetes

A

Newly diagnosed diabetic - a1c check every three months. Then once blood glucose is controlled check twice a year.

Lipids Should be checked once a year

Random urine for microalbuminuria at least once a year. Albumin to creatinine ratio is preferred.
If positive order a 24 hour urine for protein and creatinine.

22
Q

Recommendations for preventative care for DM patients

A

ShinGrix in two doses 2 to 6 months apart
Annual flu
pneumonia vaccinations
prescribe aspirin 81 mg if high-risk for MI or stroke annual eye exam is by ophthalmologist
podiatrist for older diabetics
blood pressure goal less than 130/80
biannual dental appointments

23
Q

Hypoglycemic response

A

Sweaty palms, tiredness, dizziness, rapid pulse, strange behavior, confusion, and weakness. If patient on BB -Hypoglycemic response can be blunted or blocked.

24
Q

Diabetic retinopathy on eye exam

A

Cotton wool spots or soft exudates, Neovascularization (tiny/fragile new blood vessels arterioles in retina) microaneurysms with dot and blot hemorrhages

25
Biguanides
Metformin Insulin sensitizer decreases glucose production in liver and glucose absorption in gut, increases glucose uptake from cells. side effects: GI diarrhea FIRST LINE MEDICATION
26
TZD
pioglitazone. "-glitazone" insulin sensitizer - increases insulin sensitivity in adipose tissue, skeletal muscles and in liver. side effects: weight gain & peripheral edema and liver dysfunction *** do no use in CHF patients***
27
sulfonaurea
glipizide "-zide or -ride" Stimulates insulin release, constant side effects: hypoglycemia, weight gain and many drug interactions
28
DPP-4 inhibitors
sitagliptin "-gliptin" stimulates insulin release, post prandial glucose rise delays gastric emptying and increases satiety low in hypoglycemic risk but high in cost
29
GLP-1
exenatide or Ozempic or Victoza Stimulates insulin release, post glucose rise slows gastric emptying and increases satiety side effects: GI upset - do not use in gastroparesis Recommonded in CVD patients and low hypoglycemic risk but high in cost.
30
SGLT-2 inhibitor
Canagliflozin "-gliflozin" think flo = urine. "serum glucose lost in toilet" renal glucose excretion post glucose rise. side effects: GU infections and dehydration Recommended in CVD patient and renal disease. minimal hypoglycemic risk and helpful in weight loss.